MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.phrs.2026.109685

Медицинская библиотека · Pharmacological research · 2026

Low-dose juglone attenuates pressure overload-induced cardiac hypertrophy through Lys207-dependent FoxO1 activation and mitochondrial protection.

Chen Hongyu, Yang Zhihao, Zhang Cheng, Ge Chengxin, Zhao Yingliang, Cheng Shaopeng, Wang Yilin, Chen Hao, Xu Can, Wang Dongjin, Yang Jie

СтатьяПеревод пока не подготовлен

Аннотация

Pressure overload-induced cardiac hypertrophy is characterized by mitochondrial dysfunction and redox imbalance. Here, we investigated the efficacy, safety window, and redox-regulatory mechanism of juglone, a naturally occurring 5-hydroxy-1,4-naphthoquinone. In mice subjected to transverse aortic constriction (TAC), high-dose juglone induced cardiac, hepatic, and renal toxicity, whereas 1 mg/kg/day was well tolerated and attenuated cardiac hypertrophy. Juglone also suppressed Ang II-induced cardiomyocyte hypertrophy in vitro and preserved mitochondrial ultrastructure and mitochondrial membrane potential, respiration, ATP production, and redox homeostasis. Single-nucleus RNA sequencing (snRNA-seq) revealed that juglone reduced stress-associated cardiomyocyte states and enriched calcium-handling cardiomyocytes. Integrated transcriptomic analyses, Biotin-Juglone pull-down assay, surface plasmon resonance, cellular thermal shift assays, molecular docking, and mutational analyses identified FoxO1 as a functional target of juglone. Juglone engaged the FoxO1 DNA-binding domain in a Lys207-dependent manner, and was associated with FoxO1 deacetylation, nuclear accumulation, and transcriptional activation. Activated FoxO1 induced Sesn3 transcription and restored AMPK phosphorylation at Thr172. Sesn3 silencing markedly attenuated juglone-induced AMPK activation and impaired its protective effects against cardiomyocyte hypertrophy and mitochondrial dysfunction. FoxO1 silencing, FoxO1-K207Q mutation, blockade of FoxO1 deacetylation, or inhibition of FoxO1 transcriptional activity impaired these benefits. Importantly, myocardium from patients with aortic valve stenosis-associated hypertrophy exhibited increased FoxO1 acetylation, reduced cardiomyocyte nuclear FoxO1 localization, decreased Sesn3 expression and AMPK phosphorylation, and increased 4-HNE. Collectively, low-dose juglone attenuates pathological hypertrophy and preserves mitochondrial homeostasis through the FoxO1-Sesn3-AMPK axis, while highlighting the importance of dose-dependent redox effects in determining its therapeutic efficacy and systemic toxicity.

Для цитирования: Chen Hongyu, Yang Zhihao, Zhang Cheng, Ge Chengxin, Zhao Yingliang, Cheng Shaopeng, Wang Yilin, Chen Hao, Xu Can, Wang Dongjin, Yang Jie. Low-dose juglone attenuates pressure overload-induced cardiac hypertrophy through Lys207-dependent FoxO1 activation and mitochondrial protection.. Pharmacological research. 2026. DOI: 10.1016/j.phrs.2026.109685.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.